Elodie Clerc
Research Subjects
Research Interests
Elodie Clerc has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- François Bourdon
Research and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland
1 shared publication - Jimmy Faivre
Teoxane SA Rue de Lyon 105
1 shared publication - Julien Iehl
Research and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland
1 shared publication - Mélanie Gallet
Research and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland
1 shared publication - Romain Brusini
Research and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland
1 shared publication
Latest Publications
- Open Access
- 26 July 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (8) , 1553
Comparative Preclinical Study of Lidocaine and Mepivacaine in Resilient Hyaluronic Acid Fillers
Background: Hyaluronic acid-based filler injections are now well-established aesthetic procedures for the correction of skin tissue defects and volume loss. Filler injections are becoming increasingly popular, with a growing number of injections performed each year. Although classified as a minimally invasive procedure, the introduction of a needle or a canula may remain painful for the patient. A major improvement was achieved with the incorporation of local anesthetics into the formulation for pain relief. Methods: In this study, two well-known anesthetics, lidocaine and mepivacaine, were systematically compared to assess their influence on filler mechanical and biological features. The impact of each anesthetic was monitored in terms of gel rheological properties, stability, durability, and degradation. The release profiles of each anesthetic were also recorded. Finally, the pharmacokinetics of each anesthetic in rats were assessed. Results: For all the rheological and biological experiments performed, lidocaine and mepivacaine influences were comparable. The addition of either anesthetic into a soft-tissue filler showed no significant modifications of the stability, durability, and degradability of the gel, with similar release profiles and pharmacokinetics at an equivalent concentration. Conclusions: Substituting lidocaine with mepivacaine does not impact the properties of the gels, and thus both can be equally incorporated as anesthetics in soft-tissue fillers.
- 26 July 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (8) , 1553
Open AccessComparative Preclinical Study of Lidocaine and Mepivacaine in Resilient Hyaluronic Acid Fillers
Background: Hyaluronic acid-based filler injections are now well-established aesthetic procedures for the correction of skin tissue defects and volume loss. Filler injections are becoming increasingly popular, with a growing number of injections performed each year. Although classified as a minimally invasive procedure, the introduction of a needle or a canula may remain painful for the patient. A major improvement was achieved with the incorporation of local anesthetics into the formulation for pain relief. Methods: In this study, two well-known anesthetics, lidocaine and mepivacaine, were systematically compared to assess their influence on filler mechanical and biological features. The impact of each anesthetic was monitored in terms of gel rheological properties, stability, durability, and degradation. The release profiles of each anesthetic were also recorded. Finally, the pharmacokinetics of each anesthetic in rats were assessed. Results: For all the rheological and biological experiments performed, lidocaine and mepivacaine influences were comparable. The addition of either anesthetic into a soft-tissue filler showed no significant modifications of the stability, durability, and degradability of the gel, with similar release profiles and pharmacokinetics at an equivalent concentration. Conclusions: Substituting lidocaine with mepivacaine does not impact the properties of the gels, and thus both can be equally incorporated as anesthetics in soft-tissue fillers.